Evidence of Persistent Small Airway Dysfunction |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
ABSTRACT |
|---|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Earlier, we found that acute ozone (O 3) exposure caused, along
with inflammation, greater, more protracted changes in small airway function (isovolumetric 
max at intermediate to low lung volumes) than in FVC or FEV1. To test if this distinction prevailed with
repetitive O3 exposure, we exposed eight healthy adults on four
consecutive days alternatively to filtered air (FA) and O3 (0.25 ppm × 2 h). Isovolumetric FEF25-75, max50, and max75, were grouped
into a single value representing small airway function (SAWgrp); respiratory frequency (f) and tidal volume (VT) were monitored during exercise. On Day 5, peripheral airway resistance (Rp) was measured followed by lavage. All daily spirometric and ventilatory
changes declined in magnitude (adapted) after one or more days
of O3 exposure. In addition, SAWgrp, f, and VT showed persistent
changes beginning with Day 2, denoted either by depression of
the preexposure baseline (SAWgrp) or exaggerated tachypnea during exercise. O3-induced neutrophilia (p = 0.04) was present in lavage fluid. The possible relationship between these persistent changes in small airway function, measured in days, and the likelihood of cumulative injury in the same region if exposure is long
term, is unknown.
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Keywords: adaptive response; persistent response
The use of repetitive daily exposure to assess the cumulative
effects of ozone (O3) has been a staple of clinical toxicology (1). Although virtually all these studies relied at least in part
on spirometry to plot the time course of the functional response, none was specifically designed to assess small airways.
The latter have long been a focus of clinical interest because
of their likely role in the pathogenesis of chronic lung disease
(7). Earlier experience in this laboratory suggested that O3-
induced changes in small airway function following acute exposure differed in magnitude and duration from those involving the larger central airways and the volume capacity of the
lung. Whereas recovery of FVC and FEV1 began within 30 min
of the end of exposure and was complete within 24 h, small
airway constriction, as measured by the reduction in isovolumetric (isoV). FEF25-75, max50, and max75, continued to
increase during the first 30 min postexposure and showed little
or no evidence of remission 24 h later (8). Also, whereas
the changes in FVC and FEV1 were unimodal in distribution and skewed toward minimal responsiveness, the changes in
(isoV) FEF25-75 showed a wider distribution that may have
constitute more than one mode (8). At 24 h postexposure, the
reduction in (isoV) FEF25-75 correlated significantly with the
increase in the fibrinogen level in bronchoalveolar lavage fluid
(BALF), used as a marker of plasma fluid exudation (10).
In testing the hypothesis that repetitive exposure to the same inhaled dose of O3 over a 4-d period, as might occur during an episode of photochemical smog, would affect small airways disproportionately, we compared the results among both spirometric and ventilatory variables (respiratory frequency [f] and tidal volume [VT]) for evidence of adaptive and persistent responses. As is customary, we have defined an adaptive response as one characterized by a diminution in the daily effect of O3 with repeated exposure and a persistent response as one characterized by either a depression of the baseline (spirometry) or a mean change in ventilatory pattern (f, VT) in the days following the initial exposure.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Subject Selection
We studied eight healthy young adults (five white males, two white
and one black female), 25 to 31 yr of age. Four subjects (Numbers 1, 4, 5, and 6, Table 1) had participated in O3 studies one or more years
earlier. None of the subjects smoked. We defined nonsmoking as
equivalent to a lifetime total of less than 3 pack-years plus abstinence
from smoking for at least 1 yr prior to the study. All underwent a
screening procedure consisting of a medical history, physical examination, spirometry and electrocardiogram (ECG) (12 leads) during rest,
and submaximal exercise on a treadmill (Model 20-55; Quinton, Inc.,
Seattle, WA). Minute ventilation (E) was measured throughout the
exercise test. Subjects were excluded from the study if they had a history of chronic respiratory or cardiovascular disease, upper respiratory infection during the past 6 wk, FVC, or FEV1 values 
80% predicted, or showed an apparent inability to sustain moderately heavy
exercise for at least 30 min. Information on the women's menstrual
cycle was recorded but not considered during scheduling based on our
previous findings that the cycle did not affect O3 responsiveness (9).
The study and consent forms were approved by the Committee on
Human Volunteers of the Johns Hopkins School of Hygiene and Public Health; informed consent was obtained from each subject.
|
Experimental Procedure
The study required 11 visits by each participant: once for the screening procedure and five times for each of the two regimes, O3 and filtered air (FA), that is, four consecutive days of chamber exposure followed 24 h later by bronchoscopy. The sequence of the two regimes was randomized. Participants in previous O3 studies were exempted from the screening procedure. Three or more weeks separated the O3 and FA regimes. All subjects who began the study completed it. A single exceedance of the 1 h ambient O3 standard occurred during the week that subject 5 was administered FA; he was cautioned to minimize outdoor activities. Prior to exposure, subjects were instructed to withhold vitamin supplements for 3 d and avoid caffeine-containing beverages on the morning of exposure. The exposures lasted 130 min. The first 120 min consisted of alternating 30-min periods of rest and exercise. The exposures ended with a final 10-min rest period.
The exercise level was set by controlling the speed and inclination
of the treadmill. The level selected for each subject was based on the
results of the screening submaximal exercise test. Our objective was
to induce a level of E equivalent to about 8 × FVC, thereby normalizing exposure to an index of lung size. E was measured during the
8th, 18th, and 28th min of each exercise period with the subject wearing a nose clip and breathing through a one-way valve connected to a
dry-gas meter. Respiratory frequency (f) was counted visually from
the dry-gas meter gauge; average tidal volume (VT) was calculated
from E and f. Chamber temperature was recorded during the procedure and used to convert E to BTPS. If necessary, the work load was
adjusted to maintain the desired E. The procedure was intended to
control E and allow adjustments in VT and f.
Heart rate was monitored electronically throughout exposure (Model Exersentry 3A; Computer Instruments Corp., Monroeville, PA), and arterial oxyhemoglobin saturation (SaO2) was monitored with pulse oximetry (Nellcor-200; Nellcor, Hayward, CA) during the rest period only.
FEF25-75, max50, and max75 were used to assess changes in
small airway caliber. All values following exposure were adjusted for
any changes in FVC that occurred, so that the before-after comparisons were isovolumetric. Our method of adjusting volume from the
spirometric tracing and the assumptions underlying the method were
described earlier (8, 11).
Subjects performed spirometry three times: before entering the exposure chamber (control), just before leaving the chamber (endexposure), and 25 min after leaving the chamber (25 min postexposure); all postexposure values reported are means of measurements made at endexposure and 25 min postexposure. On Day 5, the subjects underwent bronchoscopy for the measurement of peripheral airway resistance (Rp) and for bronchoalveolar lavage. Spirometry was measured in the bronchoscopy suite before and after bronchoscopy.
Spirograms were obtained in triplicate in accordance with the recommendations of the American Thoracic Society. The measurements were made with an 8-L water-sealed spirometer (Warren Collins, Inc., Braintree, MA) provided with a potentiometer connected by an analog digital converter to an IBM PC. The spirometer was calibrated daily and temperature was recorded before each set of measurements. The spirograms were reviewed visually for quality; any marred by coughing were eliminated. All spirometric variables were temperature corrected automatically and calculated using a software program developed locally. The forced expiratory effort producing the highest sum of FVC + FEV1 is reported. For the maximum flow-volume curves, the volume signal from the potentiometer was differentiated electronically to give flow; both signals were recorded using the same software.
Prior to bronchoscopy on Day 5, subjects inhaled 5 ml of aerosolized 4% lidocaine (DeVilbiss nebulizer no. 646, Somerset, PA) and
had a balloon-tipped catheter passed by nose to the lower esophagus
to measure local pressure; the latter was used as a surrogate for pleural pressure. Subjects were than placed supine and trained to breath-hold at their functional residual capacity (FRC) after three deep
breaths; reproducibility of FRC during breath-holding was checked
by esophageal pressure. All subjects were premedicated with 100 µg
of fentanyl given intravenously. Additional topical anesthesia was
achieved by instilling 2% lidocaine through the bronchoscope. Four
randomly chosen subjects also received 0.6 mg of atropine intravenously. Before the bronchoscope was wedged, the working channel
was cleaned with a brush and a #5 FR double-lumen catheter was inserted. The bronchoscope was wedged into the anterior segment of
the right upper lobe, with care taken to return to the same site on each
subject. Five percent CO2 in air was administered at a rate determined
by a mass flow controller (Sierra, Carmel Valley, CA) through one lumen of the catheter (B) while pressure at the tip of the bronchoscope
(PB) was measured through the other lumen. B was increased incrementally from 200 ml/min to 500 ml/min or until PB reached 16 cm
H2O, then decreased to 100 ml/min and finally returned to 200 ml/
min. Each flow was maintained until PB had stabilized (approximately
5 to 15 s); the subject was then instructed to take three deep breaths
and breath-hold at FRC after the third breath, while the steady-state PB was recorded. The breath-holding maneuver was repeated at least twice at each B. Rp was calculated as the average PB/B at each
static flow and averaged over five flows. The measurement has also
been referred to as collateral resistance (Rcoll) (12, 13).
After Rp was measured, the bronchoscope was withdrawn to the trachea, additional 2% topical lidocaine was given topically, if needed, and the bronchoscope was repositioned in the right middle lobe. The lobe was lavaged with five aliquots (20 ml each) of normal saline warmed to 37° C. The returns were combined and kept on ice until the end of the procedure, when small amounts were removed for determination of cell counts, cell viability, and differential staining. The samples were then centrifuged at 600 × g for 15 min at 20° C and the supernatants subdivided for measurement of albumin, fibrinogen, and kinins.
The techniques for the differential cell counts and biochemical assays were described previously (10). The kinin assay does not distinguish between bradykinin and lysylbradykinin on a molar basis.
Environmental Chamber
The details of the exposure system were described previously (10). A
free-standing chamber measuring 2.7 × 2.1 × 2.4 m, with 10-cm-thick
insulated sides, floor, and ceiling and lined on the interior with anodized aluminum, was used for exposure. The chamber could accommodate two subjects and was furnished with a spirometer, chairs, and
a treadmill controlled from outside (Model 20-55, Quinton, Inc.,
Seattle, WA). Outdoor air was supplied to the chamber air-purifier
through the central air-conditioning system that filtered coarse particulate matter and controlled air temperature and relative humidity thermostatically. The chamber flow rate was 5.6 m3/min (23.7 air changes/h,
one-pass design). Static pressure within the chamber was maintained
slightly below (
0.1 cm H2O) that of the surrounding laboratory by
adjustment of the supply damper. The mean chamber temperature
and relative humidity were 21.4 ± 0.2 (SD)° C and 46.3 ± 3.5% during
FA treatment, and 21.4 ± 0.2 and 43.9 ± 2.4% during O3 treatment.
Ozone was generated by electrical arcing (Model G1-L Ozone Generator, PCI Ozone Corp., West Caldwell, NJ) of 100% oxygen and mixed with purified air entering the chamber. The concentration of O3 in the chamber was monitored with an ultraviolet photometer (Dasibi 1003 AH; Glendale, CA) at two sites near the breathing zones for the treadmill and chairs. All tubing to the monitor was Teflon; the monitoring line valves were stainless steel. O3 monitoring was continuous during both FA and O3 exposures and was recorded every minute. The concentration per exposure was based on the mean of five evenly spaced measurements made every 20 min after the first 5 min. The mean (± SD) concentration during O3 exposure was 0.254 ± 0.001 ppm, and during FA exposure was 0.003 ± 0.001 ppm.
Statistical Analysis
We used the principal components statistical method (14) to group
the three isovolumetric spirometric measures of small airway function
(FEF25-75, max50, max75), thereby forming a single value for each
subject. The symbol used in the text to designate the value is SAWgrp.
Our rationale for selecting this method along figures showing the results for the individual components of SAWgrp is presented in the Appendix .
Analysis of longitudinal data. Because repeated measures on the same subject violate the assumption of independence in linear regression, we used a "mixed effects" (combined fixed and random effects) regression model to analyze the longitudinal data on spirometric and ventilatory variables:
Outcome = 
0 + 1*O3 + 2*day + 3*O3* day + b1* subject
where 0 was the intercept, the explanatory variables included O3
treatment modeled as a binary variable, day of exposure as a categorical variable, O3*day as an interaction, and b1* subject, the study population, as the random effect (15). The analyses were performed on untransformed data and included the following: differences between FA
and O3 treatments: a, overall regression coefficients; b, paired points;
differences within each treatment: c, daily pre- to postexposure changes
to assess adaptive responses; d, day-to-day changes in baseline (spirometry) or mean value (f and VT during exercise) to assess persistent responses. Significant changes in the components of the model are cited
in the figures. Significance was taken as p < 0.05.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
During exercise, overall E averaged 38.6 ± 2.5 (SEM) L/min
on FA and 39.1 ± 2.1 L/min on O3. The mean values on individual days ranged between 38.1 ± 2.8 L/min and 39.1 ± 2.6 L/min on FA, and between 38.1 ± 2.1 L/min and 39.8 ± 2.2 L/min on O3. No significant trends were noted over the 4-d periods. The overall targeted E was 39.5 ± 2.3 L/min.
Spirometry
The coefficients of variation for all spirometric variables including the small airway group (SAWgrp) are shown in Table 2; the values were based on FA breathing. Similar gradients in measurement error have been reported before (11, 16). The coefficient of variation was highest among the small airway variables, tending to increase as lung volume and flow rate fell. Such large coefficients clearly limit the utility of these measurements for detecting functional change.
|
The time course of the adaptive response differed slightly
among spirometric variables (Figure 1). The maximal mean
reductions in FVC and FEV1 occurred on Day 2 of exposure
to O3; 7.7 ± 4.5% (SEM) (p < 0.01, model components b, c,
and d) and 9.1 ± 5.7% (p < 0.01, model components b, c,
and d), respectively. By Day 4, these daily changes were negligible. The maximal mean reduction in the SAWgrp occurred
on Day 1 of exposure, 6.7% (p < 0.05, component b), and
thereafter dissipated rapidly.
|
The only spirometric variable to show a persistent response with repetitive O3 exposure was the SAWgrp (Figure 2). By Day 2, the SAWgrp baseline was depressed by 6.9 ± 3.5% (p = 0.06, component c) and remained depressed by slightly more than 8% (p < 0.05, component c) over the next 3 d. This persistent effect exceeded in magnitude the maximal pre- to postexposure reduction in the same variable seen on Day 1 (Figure 1).
|
Breathing Pattern
To test for evidence of an adaptive response affecting the pattern of breathing, we compared the magnitude of within-day changes in f and VT across the 4 d of exposure. The changes occurred between the 10th and 60th minutes of exercise, that is, between the first and last of six measurements made during exercise (Figure 3).
|
The maximal mean increase in f during O3 exposure occurred on Day 2, +6.6 ± 2.7 (SEM) breaths/min (BPM) or
+30% (p < 0.01, component d). By Day 4, the change was indistinguishable from that seen with FA. (Respiratory frequency tended to increase slightly over the course of exercise
on FA. On Day 4, this increase was similar for FA and O3 although absolute f was higher with O3.) The maximal mean reduction in VT during O3 exposure occurred on Day 3, 0.36 ± 0.09 L or 19% (p < 0.01, component d). Evidence of an
adaptive response appeared the next day: 0.22 ± 0.08 L or
11% (p < 0.05, component d).
To test for evidence of persistent changes in breathing pattern attributable to O3, we compared the mean values for f and VT on Day 1 (based on all six measurements) against the means on the remaining 3 d (Figure 4). In effect, the pattern of breathing on the first day of exposure constituted the "baseline." (The means on Day 1 were similar for FA and O3. Either could have served as baseline and yielded the same outcome. We selected the O3 values to conform to the analysis carried out on the spirometric variables, as in Figure 2.)
|
On Day 2 of O3 exposure, mean f was elevated by +4.7 ± 2.7 BPM or +22% (p < 0.01, component c), then gradually tapered off to +3.2 ± 1.4 BPM or +15% by Day 4 (p = 0.06, component c). Mean VT was reduced by 0.2 ± 0.1 L or
14% (p < 0.01, component c) on Day 2 and remained at essentially this level thereafter. This persistent pattern of more
rapid, shallow breathing is foreshadowed in Figure 3: note that
beginning with Day 2, the first of the six measurements of f
and VT were at new levels compared with Day 1, further evidence of "carryover" effects on the control of breathing.
BALF Content
The total cell count (Day 5) tended to be higher after O3 than FA, but the difference was not significant (p = 0.26 [Table 3]). The neutrophilic (polymorphonuclear, PMN) count was significantly higher after O3: + 61% (p = 0.04). None of the cell types, expressed as percentages of total cells, differed significantly in the two circumstances.
|
The mean levels of albumin, fibrinogen, and kinins were not significantly different after O3 and FA. Nonetheless, these findings were notable in two respects: O3-FA differences in all three variables were strongly interdependent within subjects and varied widely in magnitude among subjects. Thus, a, the correlation coefficients (r) for the O3-FA differences among the three variables, ranged between 0.84 and 0.93 (p < 0.01); b, the percentage increases in albumin, fibrinogen, and kinins in the two subjects with the most marked exudative responses, exceeded the mean changes for the group, respectively, by 10-fold, 15-fold, and 2-fold (Subject 2), and by 45-fold, 17-fold, and 7-fold (Subject 4).
Correlations between the changes in exudative markers
and PMN counts were negligible (r = 0.05 to 0.20). Correlations between the changes in both exudative markers of inflammation and PMN counts and the level of depression of
the small airway baseline (SAWfactor1; see Appendix for derivation) on Day 5 were inverse and weak (r = 0.30 to 0.46);
the highest value, 0.46 (p = 0.26), was found between the
changes in fibrinogen and SAWfactor1). Correlations between
the changes in PMN counts and changes in both f and VT on
Day 5 were moderately strong (r = 0.52 and 0.65, respectively), but appeared paradoxical, that is, as PMN influx increased, the degree of rapid shallow breathing decreased. A similar paradoxical association between the degree of neutrophilia
and the decline in FEV1 has been seen following acute O3 exposure (17, 18).
Peripheral Airways Resistance
Rp, measured in tandem with bronchoalveolar lavage (BAL), appeared unaffected by repetitive O3 exposure. Atropine was withheld in four subjects prior to bronchoscopy with no apparent effect on the outcome. The respective Rp values in cm H2O/ml/min (mean, range) after O3 and Fa were as follows: with atropine pretreatment, 0.027 (0.002 to 0.066) versus 0.027 (0.003 to 0.063); with atropine withheld, 0.014 (0.003 to 0.038) versus 0.023 (0.003 to 0.069).
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Functional Response
Repetitive exposure to 0.25 ppm O3 over a 4-d period elicited
two patterns of response, adaptive and persistent. All spirometric and ventilatory variables underwent adaptive changes.
The changes varied in day of onset. The SAWgrp, a composite
of (isoV) FEF25-75, max50, and max75, was first to adapt
(Day 1), followed 1 d later by FVC, FEV1, and by f, and VT on
the last day of exposure (Figures 1 and 3).
Adaptive responses to O3 involving FVC, FEV1, symptoms of respiratory irritation, bronchial reactivity, exercise performance, and, more recently, a number of inflammatory markers are well documented (1, 4). Functional adaptation, as measured by FEV1, has been seen despite cellular and biochemical evidence in BALF of ongoing inflammation, and of neutrophil infiltration in bronchial mucosa (6). To our knowledge, volume-corrected spirometric measures or other indices of small airway function have not been examined before in a similar way. Evidence of an adaptive change in breathing pattern with repetitive O3 exposure, particularly of f, was first described by Foxcroft and Adams (19, Figure 2). (That acute exposure elicits progressive tachypnea during exercise at concentrations at or above 0.20 to 0.25 ppm is also well documented [1, Table 7-1].) The onset of an adaptive response appears to be influenced by both the level of exposure and sensitivity of the individual to O3. More intense exposure and increased sensitivity are likely to delay the onset (1, 20).
The small airway composite measure alone among spirometric variables displayed a persistent preexposure baseline
depression, beginning with Day 2 (Figure 2). This dichotomy
between the SAWgrp and both FVC and FEV1 accords with
earlier results seen following acute O3 exposure, namely, that
FVC and FEV1 recovered more rapidly than (isoV) max (9,
10). Persistent depression of the FVC and FEV1 baselines
have generally been uncommon or marginal during repetitive
O3 exposure at concentrations 0.4 ppm (2, 3, 5, 20, 22).
Our method of adjusting the three components of the SAWgrp for O3-induced changes in FVC (thereby solving for intrinsic changes in small airway caliber) relies on two assumptions, namely, that O3 exposure has little or no effect on either residual volume (RV) or lung elastic recoil. To our knowledge, neither assumption has been tested experimentally with repetitive exposure. Hazucha and coworkers (23) concluded that the reduction in FVC following acute O3 exposure (0.5 ppm × 2 h) was not attributable to the small increase in RV (+11%, p < 0.05) or the tendency toward an increase in elastic recoiling force they observed. Beckett and coworkers (0.4 ppm × 2 h) (24) and our group (0.35 ppm × 130 min) (8, 9) found no significant change in RV following acute exposure. It is to be noted that an increase in RV, as might occur if partially obstructed small airways closed prematurely during forced expiration, would act to diminish the calculated reduction in isovolumetric flow. Similarly, an increase in elastic recoil would, if transmitted to the outer walls of intrapulmonary airways, act as a distending force to preserve maximal flow at low lung volumes (25).
Although we did not determine the time required for the small airway dysfunction to remit, we suspect it is tied to complete remission of the inflammatory process, as discussed in the next section. Whether the dysfunction may serve as a forerunner of more permanent loss is an open question. Permanent loss might follow in the event that O3 exposure is repeated over extended periods of time or individuals are unusually reactive to O3, as Subjects 2 and 4 appeared to be. Recently, Künzli and coworkers (26) reported finding a significant correlation between estimated lifetime exposure to ambient O3 among college freshmen (lifetime residents of California) and impaired small airway function. The latter was assessed spirometrically, based on FEF25-75% and FEF75%; FVC and FEV1 were unaffected. Additional epidemiological and field studies to test possible intermediate and long-term effects of photochemical air pollution on small airways appear indicated.
Inflammatory Response
In our study of the acute effects of O3, the levels of albumin,
fibrinogen, kinins, and PMN (both absolute number and percentage of total cell count) were significantly elevated 24 h
postexposure (10). In the present study, only the absolute number of PMN remained elevated by Day 5. In the earlier study,
the changes in fibrinogen, a marker of plasma transudation,
and (isoV) FEV25-75 were inversely and strongly correlated (r = 0.88; p = 0.001; n = 8); the spirometric measurement had
also been made 1 d postexposure and, in effect, represented a
"persistent" change of at least 24 h. In the present study, the
changes in fibrinogen correlated inversely but weakly with
the degree to which the small airway baseline, expressed as
SAWfactor1, was depressed (r = 0.46; p = 0.26; n = 8). Together, these findings are consistent with a general waning of
the exudative component of the inflammatory response following repetitive O3 exposure, as reported by other investigators (4). The exceptionally high levels of exudative markers
in two subjects (Numbers 2 and 4) also conform to previous evidence of wide differences in inflammatory activity among
healthy subjects following repetitive exposure (5, Figure 3).
Mechanisms
We propose that both the adaptive and persistent functional
responses were byproducts of inflammatory changes set in
motion on the first day of exposure. The former reflects the
protective action of inflammation and the latter reflects the
functional inefficiencies
or costsassociated with that protection. We use the term "inflammation" broadly to include
increased vascular permeability, cellular influx, release of mediators, and any responses these primary events may entrain.
Although the acute inflammatory response is emblematic of tissue injury, it also is viewed as an adjustment that helps confine injury and defends against further environmental challenge (27). Plasma exudate contains elements that can interrupt the cascade of chemical reactions associated with lipid peroxidation (28), scavenge reactive oxygen species (albumin, a traditional marker of transudation, is, itself, an effective antioxidant [29]), limit tissue injury, and stimulate repair and regeneration (31). Mucorrhea and increased airway smooth muscle tone, frequent accompaniments of inflammation, may interfere mechanically with local gas flow and additional O3 transport to inflamed sites. That the epithelial lining fluid, as a result of inflammatory changes in volume and composition, is likely to be a more effective barrier against oxidative stress is implicit in the O3 transport model (32, Figures 2 and 4). Several of these factors have indeed been cited as promoters of functional and symptomatic adaptation to O3.
Admittedly, the generally weak correlations between inflammatory and persistent functional changes provide little support for our proposition that the latter reflect the inefficiencies of an otherwise protective response. Nonetheless, we do not regard them as voiding the proposition. Although useful diagnostically, bronchoalveolar lavage is an invasive procedure that cannot provide an adequate accounting of a process as complex and nonlinear in its dynamics as inflammation. Estimates of the interdependencies between inflammatory and functional responses are therefore subject to considerable uncertainty. Insofar as functional and inflammatory responses follow different time courses, the apparent strength of their interdependency will be sensitive to the timing of each measurement.
Tachypnea
Stimulation of afferent vagal fibers (bronchial C-fibers) is considered the chief basis for the rapid, shallow breathing (during exercise), chest discomfort, and reduced inspiratory capacity associated with acute O3 exposure (23, 33, 34). It is therefore difficult to reconcile the persistent tachypnea seen during repetitive exposure with the absence of analogous changes in FVC and FEV1, unless another mechanism keyed solely to the control of breathing is invoked. A plausible candidate for this role is a change in the viscoelastic properties of the distal lung, triggered by the tissue injury and inflammation that accompany the first day's exposure to O3. The rationale for this potential mechanism was developed decades ago to explain breathlessness during exercise.
The pattern of breathing used to achieve a specific E is
highly variable (35). Campbell (36) postulated that information about respiratory muscular and mechanical behavior is
processed unconsciously by the cortex, which exerts "unconscious control" of the breathing pattern. If, as a consequence
of O3-induced injury and inflammation, tissue viscance (Vti)
were increased out of proportion to any narrowing of the large
conducting airways, more rapid, shallow breathing would
likely follow, especially with exercise (37, 38). This adjustment
in breathing pattern should mitigate respiratory discomfort or
breathlessness arising from the altered mechanical behavior of
the distal lung.
The premise about the O3-induced change in Vti is untested. Certainly, constriction of large, central airways, as reflected in an increase in airway resistance (SRaw or Raw), is not a prominent feature of the response to acute exposure (17, 23, 34) and should not exact a high cost in work during tachypnea. Moreover, with repetitive exposure, SRaw adapts readily and has shown little or no baseline elevation (5, 39). In our study, the underlying adjustment of the respiratory pattern did not occur until Day 2 when, presumably, tissue injury and inflammatory changes were more fully established. The proposed change in Vti does not imply a parallel change in Rp, which was unaffected. The two measures may be governed by anatomically distinct contractile elements, as evidenced by their dissimilar responses to histamine and leukotriene C4 aerosols (13).
Peripheral Airway Resistance
As noted above, Rp was unaffected by repetitive O3 exposure notwithstanding the evidence of persistent small airway narrowing and inflammation of the peripheral lung. This dichotomy between collateral and small airway responses was also seen after acute O3 exposure (10). Following the acute exposure, all subjects prior to bronchoscopy received atropine, a cholinergic antagonist, and lidocaine, a topical anesthetic. In the present study, atropine was withheld from half of the subjects without affecting the outcome. It would appear that either the dose of O3 to the airways responsible for Rp was negligible relative to the dose to small airways, the former airways were highly resistant to O3, or that lidocaine premedication abolished any increase in Rp that might have occurred. We favor the first of these possibilities. Consistent with our findings is the recent observation that in anesthetized, mechanically ventilated dogs, 0.2 ppm O3 administered for 6 h by endotracheal tube had no effect on Rp unless the animals were pretreated with probenecid, an inhibitor of endogenous antioxidant transport. In contrast, pulmonary resistance increased in both untreated and pretreated animals (40).
Collateral channels having the structural characteristics of respiratory bronchioles and alveolar ducts appear to be chiefly responsible for Rp (12). They represent diffusion pathways in normal lungs. Small airways, which dominate maximal expiratory flow at intermediate to low lung volumes, are likely to include subsegmental bronchi and membranous bronchioles. Opposing views have been expressed about whether collateral channels have a significant role in gas exchange in the normal lung (12, 41). Our results are consistent with their having a minor role, especially among healthy young adults.
In summary, we observed two patterns of functional response among healthy, young adults exposed repetitively to O3, adaptive and persistent. All spirometric variables, as well as f and VT, underwent adaptive changes. Spirometric evidence of persistent change was confined to small airways; rapid, shallow breathing during exercise also persisted. Neutrophilia in BALF was evident 1 d following the end of O3 exposure. We suggest that both types of functional response are linked causally to inflammation. The adaptive component is attributable at least in part to a reduction in local tissue dose during repetitive exposure that is likely to result from the biochemical, mechanical, and morphological changes set in motion by inflammation. The persistent component represents the inefficiencies incurred through inflammation. Whether the persistent small airway dysfunction is a forerunner of more permanent change in the event that oxidant stress is extended over lengthy periods of time is unclear.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Robert Frank, M.D., Department of Environmental Health Sciences, The Johns Hopkins School of Hygiene and Public Health, 615 North Wolfe Street, Room W6010, Baltimore, MD 21205. E-mail: rfrankjhsph.edu
(Received in original form October 7, 2000 and accepted in revised form June 13, 2001).
Acknowledgments: The authors are grateful to both Brian Rooney, who would have been a coauthor but for the constraints imposed by his new vocation, and David Simon, Department of Epidemiology, for statistical guidance; and to Arthur Freed, Ph.D. for his thoughtful, constructive review of the manuscript.
Supported by Grants ES03819 and ES03505 from the National Institute of Environmental Health Science of the NIH.
| |
References |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1. U.S. Environmental Protection Agency. Air quality criteria for ozone and related photochemical oxidants. Washington, D.C.: Office of Research and Development; 1996, Volume III, Chapter 7.
2.
Foster WM,
Wills-Karp M,
Tankersley CG,
Chen X,
Paquette NC.
Bloodborne markers in humans during multiday exposure to ozone.
J Appl Physiol
1996;
81:
794-800
3. Gong H Jr,, McManus MS, Linn WS. Attenuated response to repeated daily ozone exposures in asthmatic subjects. Arch Environ Health 1997; 52: 34-41 [Medline].
4. Devlin R, Folinsbee L, Biscardi F, Hatch G, Becker S, Madden M, Robbins M, Koren H. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhal Toxicol 1997; 9: 211-235 .
5.
Christian DL,
Chen LL,
Scannell CH,
Ferrando RE,
Welch BS,
Balmes JR.
Ozone-induced inflammation is attenuated with multiday exposure.
Am J Respir Crit Care Med
1998;
158:
532-537
6.
Jörres RA,
Hotz O,
Zachgo W,
Timm P,
Ksochyk S,
Muller B,
Grimminger F,
Seeger W,
Kelly FJ,
Dunster C, et al
.
. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and
mucosal biopsies.
Am J Respir Crit Care Med
2000;
161:
1855-1861
7. Bates DV. Historical introduction: the evolution of understanding the small airways. Sem Respir Med 1992; 13: 63-71 .
8. Weinmann GG, Bowes SM, Gerbase MW, Kimball AW, Frank R. Response to acute ozone exposure in healthy men. Results of a screening procedure. Am J Respir Crit Care Med 1995; 151: 33-40 [Abstract].
9. Weinmann GG, Weidenbach-Gerbase M, Foster WM, Zacur H, Frank R. Evidence for ozone-induced small-airway dysfunction: lack of menstrual-cycle and gender effects. Am J Respir Crit Care Med 1995; 152: 988-996 [Abstract].
10. Weinmann GG, Liu MC, Proud D, Weidenbach-Gerbase M, Hubbard W, Frank R. Ozone exposure in humans: inflammatory, small and peripheral airway responses. Am J Respir Crit Care Med 1995; 152: 1175-1182 [Abstract].
11. Preutthipan A, Frank R, Weinmann GG. A method for assessing small airways independent of inspiratory capacity. Arch Environ Health 1996; 51: 47-51 [Medline].
12. Mitzner W. Collateral ventilation. In: Crystal RG, West JB, editors. The lung: Scientific foundations. Philadelphia: Raven Press, Ltd.; 1997. p. 1425-1435.
13.
Ludwig MS,
Shore SA,
Fredburg JJ,
Drazen JM.
Differential responses
of tissue viscance and collateral resistance to histamine and leukotriene C4.
J Appl Physiol
1988;
65:
1424-1429
14. SAS Institute, Inc. SAS/STAT® User's guide, Version 6, 4th ed. Cary, NC: SAS Institute, Inc.; Vol. 1, ch. 21:774-821.
15. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford: Clarendon Press; 1994. Appendix A.
16. Tager IB, Künzli N, Ngo L, Balmes J. Methods development for epidemiologic investigations of the health effects of prolonged ozone exposure. Part 1: Variability of pulmonary function measures. Health Effects Institute Research Report No. 81; 1998. p. 1-25.
17. Schelegle ES, Siefkin AD, McDonald RJ. Time-course of ozone-induced neutrophilia in normal humans. Am Rev Respir Dis 1991; 143: 1353-1358 [Medline].
18. Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993; 148: 1363-1372 [Medline].
19.
Foxcroft WJ,
Adams WC.
Effects of ozone exposure on four consecutive
days on work performance and O2max.
J Appl Physiol
1986;
61:
960-966
20. Folinsbee LJ, Bedi JF, Horvath SM. Respiratory responses in humans repeatedly exposed to low concentrations of ozone. Am Rev Respir Dis 1980; 121: 431-439 [Medline].
21. Horvath SM, Gliner JA, Folinsbee LJ. Adaptation to ozone: duration of effect. Am Rev Respir Dis 1981; 123: 496-499 [Medline].
22. Folinsbee LJ, Horstman DH, Kehrl HR, Harder S, Abdul-Salaam S, Ives PJ. Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med 1994; 149: 98-105 [Abstract].
23.
Hazucha MJ,
Bates DV,
Bromberg PA.
Mechanism of action of ozone
on the human lung.
J Appl Physiol
1989;
67:
1535-1541
24. Beckett WS, McDonnell WF, Horstman DH, House DE. Role of the parasympathetic nervous system in acute lung response to ozone. J Appl Physiol 1985; 59: 1179-1185 .
25.
Mead J,
Turner JM,
Macklem PT,
Little JB.
Significance of the relationship between lung recoil and maximum expiratory flow.
J Appl Physiol
1967;
22:
95-108
26.
Künzli N,
Lurmann F,
Segal M,
Ngo L,
Balmes J,
Tager IB.
Association
between lifetime ambient ozone exposure and pulmonary function in
college freshmenresults of a pilot study.
Environ Res
1997;
72:
8-23
[Medline].
27. Persson CGA, Erjefält I, Alkner U, Baumgarten C, Grieff I, Gustafsson B, Lutz A, Pipkorn U, Sundler F, Svensson C, et al . . Review. Plasma exudation as a first line respiratory mucosal defense. Clin Exp Allergy 1991; 21: 17-24 [Medline].
28. Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1993; 924: 408-419 .
29.
Halliwell B.
Commentary: albuminan important extracellular antioxidant?
Biochem Pharmacol
1988;
37:
569-571
[Medline].
30. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity. Free Radic Biol Med 1995; 19: 935-941 [Medline].
31. Shami SG, Evans MJ, Martinez LA. Type II cell proliferation related to migration of inflammatory cells into the lung. Exp Mol Pathol 1986; 44: 344-352 [Medline].
32. Miller FJ, Overton JH Jr,, Jaskot RH, Menzel DB. A model of the regional uptake of gaseous pollutants in the lung. I. The sensitivity of the uptake of ozone in the human lung to lower respiratory tract secretions and exercise. Toxicol Appl Pharmacol 1985; 79: 11-27 [Medline].
33.
Coleridge JCG,
Coleridge HM,
Schelegle ES,
Green JF.
Acute inhalation of ozone stimulates bronchial C-fibers and rapidly adapting receptors in dogs.
J Appl Physiol
1993;
74:
2345-2352
34. Bromberg PA, Koren HS. Ozone-induced human respiratory dysfunction and disease. Toxicol Lett 1995;82/83:307-316.
35.
Mead J. Mechanical factors in the control of breathingthree problems.
In: Howell JBL, Campbell EJM, editors. Breathlessness. Philadelphia:
F.A. Davis Co.; 1966. p. 139-146.
36. Campbell EJM. The relationship of the sensation of breathlessness to the act of breathing. In: Howell JBL, Campbell EJM, editors. Breathlessness. Philadelphia: F.A. Davis Co.; 1966. p. 55-64.
37.
Hildebrandt J.
Dynamic properties of air-filled excised cat lungs determined by liquid plethysmograph.
J Appl Physiol
1969;
27:
246-250
38.
Karija ST,
Shore SA,
Skornik WA,
Anderson K,
Ingram RH Jr,,
Drazen JM.
Methacholine-induced bronchoconstriction in dogs: effects of lung
volume and O3 exposure.
J Appl Physiol
1988;
65:
2679-2686
39. Dimeo MJ, Glenn MG, Holtzman MJ, Sheller JR, Nadel JA, Boushey HA. Threshold concentration of ozone causing an increase in bronchial reactivity in humans and adaptation with repeated exposures. Am Rev Respir Dis 1981; 124: 245-248 [Medline].
40.
Freed AN,
Cueto R,
Pryor WA.
Antioxidant transport modulates peripheral airway reactivity and inflammation during ozone exposure.
J
Appl Physiol
1999;
87:
1595-1603
41.
Morrell NW,
Roberts CM,
Biggs T,
Seed WA.
Collateral ventilation and
gas exchange during airway occlusion in the normal human lung.
Am
Rev. Respir Dis
1993;
147:
535-539
[Medline].
| |
APPENDIX |
|---|
We knew from experience gained in this and other laboratories
of the large coefficient of variation associated with max at low
lung volumes (11, 16) where, theoretically, max is most reflective of small airway caliber (25). We judged that eight subjects
would suffice for an adequate test of our hypothesis about the
asymmetries between volume-dependent (FEV1, FVC) and isovolumetric small airway (FEF25-75, max50, max75) measures
in response to repetitive O3 exposureif the variability of these
data could be reduced. The principal components statistical model served this end. The model is intended to reduce the number of measures that are related conceptually by grouping them,
thereby reducing the variability of the same data. A table of the
analytic results affirming the appropriateness of grouping the
three measures into one functional entity (SAWgrp) is available
upon request. The adaptive and persistent responses among the
individual components are shown in Figures 5 and 6, respectively.
Their marked variability relative to that of SAWgrp (Figures 1
and 2) is evident. The greater clarity of outcome associated with
the SAWgrp analysis is also evident. We believe the model holds
promise as a means of tracking small airway function. But because the observation of persistent small airway narrowing attending repetitive O3 exposure is novel and is based on a limited
number of test subjects, replication is needed.
|
|
Each individual SAWgrp value retained the original number of observations (n = 3). To permit correlations between SAWgrp and other variables, that is, BALF contents, f and VT, it was necessary to reduce n from three to one per subject. This step involved normalizing and then recombining the three spirometric variables based on their relative "weightings." The weightings were calculated with a second principal components model and were based on the percentage changes in each of the variables associated with exposure to FA and O3. This modified value is symbolized by SAWfactor1. To calculate correlation coefficients (r), all data were transformed logarithmically.
This article has been cited by other articles:
 |
|
 |
|
  M. L. Bell, A. McDermott, S. L. Zeger, J. M. Samet, and F. Dominici Ozone and Short-term Mortality in 95 US Urban Communities, 1987-2000 JAMA, November 17, 2004; 292(19): 2372 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Romieu, J. J. Sienra-Monge, M. Ramirez-Aguilar, M. M. Tellez-Rojo, H. Moreno-Macias, N. I. Reyes-Ruiz, B. E. del Rio-Navarro, M. X. Ruiz-Navarro, G. Hatch, R. Slade, et al. Antioxidant Supplementation and Lung Functions among Children with Asthma Exposed to High Levels of Air Pollutants Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |